Masahiro Aoki

Nagoya, 4648681, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy.

Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy.

Journal: Cell reports. Medicine
Published: May 27, 2024

TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulation.

TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulation.

Journal: Cancer science
Published: June 22, 2023

L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis.

L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis.

Journal: Oncogene
Published: October 22, 2022

Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.

Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.

Journal: Nature communications
Published: July 16, 2022

Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.

Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.

Journal: Cancer science
Published: July 01, 2022

The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells.

The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells.

Journal: Cancer research
Published: April 24, 2022

MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.

MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.

Journal: Cancer science
Published: June 07, 2021

Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.

Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.

Journal: Cancer gene therapy
Published: August 26, 2020

Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells.

Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells.

Journal: Oncogene
Published: June 04, 2020

Basic Science of Cancer Cachexia

Basic Science of Cancer Cachexia

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 28, 2019

Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in ApcΔ716 mutant mice.

Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in ApcΔ716 mutant mice.

Journal: Cancer science
Published: February 21, 2019

Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms.

Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms.

Journal: Cancer chemotherapy and pharmacology
Published: September 24, 2018
Showing 1-12 of 30

Last Updated: 09/26/2026